Emergent Health Corp
Emergent Health Corp. develops and sells regenerative medicine, neutraceuticals, and phytonutritionals. Its products comprise Vita-Stim, a nutrient that enhances the immune system, nourishes stem cells, and maintains health; Neuvitale, which nourishes stem cells and acts as a methyl donor to protect DNA; Hungarest, a diet aid that controls appetite in the brain and stomach; EmergentO2, water oxyg… Read more
Emergent Health Corp (EMGE) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2024: 0.018x
Based on the latest financial reports, Emergent Health Corp (EMGE) has a cash flow conversion efficiency ratio of 0.018x as of September 2024.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-56.47K) by net assets ($-3.16 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Emergent Health Corp - Cash Flow Conversion Efficiency Trend (2010–2023)
This chart illustrates how Emergent Health Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Emergent Health Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Emergent Health Corp ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
NUWEW
PINK:NUWEW
|
N/A |
|
First Republic Corp. of America
PINK:FRPC
|
0.055x |
|
PRESTIGE ASSURANCE CO. PLC
XNSA:PRESTIGE
|
N/A |
|
Postd Merchant Banque
PINK:PMBY
|
N/A |
|
Winners Inc
PINK:WNRS
|
0.011x |
|
All American Gld Crp
PINK:AAGC
|
10.069x |
|
Fifty 1 Labs, Inc.
PINK:FITY
|
1.451x |
|
Gemini Group Global Corp
PINK:GMNI
|
N/A |
Annual Cash Flow Conversion Efficiency for Emergent Health Corp (2010–2023)
The table below shows the annual cash flow conversion efficiency of Emergent Health Corp from 2010 to 2023.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-12-31 | $-2.35 Million | $-1.22 Million | 0.519x | -71.03% |
| 2022-12-31 | $-1.06 Million | $-1.90 Million | 1.790x | +135.02% |
| 2021-12-31 | $31.63K | $-161.63K | -5.110x | -3670.63% |
| 2019-12-31 | $400.22K | $-54.24K | -0.136x | -268.55% |
| 2013-12-31 | $957.28K | $76.97K | 0.080x | +329.80% |
| 2012-12-31 | $836.25 | $-29.26 | -0.035x | +11.08% |
| 2011-12-31 | $743.63K | $-29.26K | -0.039x | +45.64% |
| 2010-12-31 | $404.22K | $-29.26K | -0.072x | -- |